Even Healthcare raises Rs 252 crore in Series A funding to launch hospital operations, enhance patient care MD Bureau24 Oct 2024 5:32 PM ISTBengaluru: Even Healthcare, a Bengaluru-based managed care provider, recently secured USD 30 million (approximately Rs 252 crore) in a Series A...
Piramal Pharma Reports Over Fourfold Surge in Q2 Net Profit to Rs 23 Crore, Announces Expansion Plans MD Bureau24 Oct 2024 4:35 PM ISTRevenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, Piramal Pharma said.
Mankind Pharma Completes Rs 13,768 Crore Acquisition of Bharat Serums MD Bureau24 Oct 2024 2:39 PM ISTSanjiv Navangul, MD & CEO, BSV, said that being a part of the Mankind Pharma family makes BSV bigger, stronger and better.
Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition MD Bureau24 Oct 2024 2:09 PM IST"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.
David Joyner Takes Helm at CVS Amid Aetna Challenge MD Bureau24 Oct 2024 9:45 AM ISTNew York: As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure recently, Wall Street analysts and some...
Zydus Secures WHO Approval for Typhoid Vaccine ZyVac TCV, Eligible for UN Procurement MD Bureau23 Oct 2024 6:46 PM ISTZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad.
Masina Hospital appoints Dr Akash Rajpal as Chief Operating Officer MD Bureau23 Oct 2024 4:37 PM ISTMumbai: Masina Hospital recently announced the appointment of Dr Akash Rajpal as its new Chief Operating Officer (COO).Bringing over 25 years of...
Camurus faces USFDA rejection on Acromegaly drug CAM2029 MD Bureau23 Oct 2024 4:21 PM ISTThe FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with acromegaly.
Novo Nordisk's oral Semaglutide cuts cardiovascular risks by 14 percent, study finds MD Bureau23 Oct 2024 3:29 PM ISTNovo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year.
NHS to Block Eli Lilly's Alzheimer's Drug Donanemab Over Cost Concerns: Report MD Bureau23 Oct 2024 2:43 PM ISTThe National Institute for Health and Care Excellence (NICE), which decides what drugs are available on the NHS, will rule that it is too expensive
Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59 MD Bureau23 Oct 2024 2:37 PM ISTThe approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
